Plesner
Sture Rygaard advises on Danish and EU IP law and leads a considerable number of litigation in patents, trademarks and product imitations (design / copyright / marketing law). Sture also advises on IP strategy and due diligence.
In the Life Science area, Sture advises clients in the pharmaceutical and biotech industries and has obtained a number of bans on drugs and biotech inventions.
Sture assists clients in enforcing a number of trademark and design rights. Lawsuits and proof-of-court cases are an essential part of this work, and he has experience in obtaining bail-out bans with effect for the entire EU based on EU trademarks.
Sture is a Member of the Board of Directors of EPLAW (2017-), Chairman of the AIPPI Standing Committee on Trade Secrets (2017-) and Vice Chairman of the Association for Industrial Legal Protection (FIR). Sture has contributed to a number of books in the field of IP and Life Science, including the "European Patent Court" which provides a detailed review of the judicial process at the Common Patent Court. Sture regularly gives lectures at seminars and conferences.
Plesner
Plesner is one of Denmark's leading law firms. We maintain special focus on assignments involving our clients' material assets, and our clients especially come to us for solutions to such assignments.